PharmAbcine Inc. announced a private placement to issue 5,302,565 share at an issue price of KRW 700 per share for the gross proceeds of KRW 3,711,795,500 on June 14, 2024. The transaction will include participation from individual investors Kim Jung Gyu 1,000,000 shares,Sungyeon Kim 1,000,000 shares, Suyeon Kim 1,000,000 shares, Seungyeon Kim 1,000,000 shares, Jinho Lee 28,572 shares, Lee Da Som  28,572 shares, Lim Hyun Mook 42,858 shares, Jaehyun Kim 42,858 shares, Byungjae Han 57,143 shares, Jung Il Lee 14,286 shares, Ahn Sung-hwan 71,429 shares, Lee Jeung-hoon 71,429 shares, Seo Jeong-gil 14,286 shares, Woo Seung Jin 28,572 shares, Dayeon Woo 42,858 shares, Maeng Pil Jae 28,572 shares, Yoo Jin San 142,858 shares, Lee Won-seop 71,429 shares, Heeyoung Park 71,429 shares, Sungjin Kim 43,000 shares, Jina Kim 30,000 shares, Buyeon Kim 24,300 shares, Soobin Hwang 21,429 shares, Kwak Geun-hwa 21,429 shares, Kidae Kim 20,000 shares, Dayeon Bae 15,715 shares, Park Beom Yong 15,700 shares, ,Nam Joo Ryung 7,000 shares, Sojung Lee 5,000 shares, Myungsun Kim 5,000 shares, Dongin Lee 4,500 shares, Kang Nu Ri 4,050 shares, Eunyoung Seo 2,858 shares, Soyoung Yang 1,500 shares, Youngae Lee 1,500 shares, Byun Sang-soon 1,500 shares, Hyerim Yoon 1,500 shares, Jin Hyun Park 1,429 shares, Hyojin Hwang 1,000 shares, Namye Kim 1,000 shares, Euna Lee 1,000 shares, Lee Yeon Joo 715 shares, Jung Yoonki 14,286 shares, Nam Jungsoo 14,286 shares, Kim Yoo-jung 14,286 shares, Hyunjung Cho 71,429 shares, Bio Holdings 42,858 shares, Harvestin Company Co., Ltd. 142,858 shares and Spera Research Co., Ltd. 14,286 shares. The transaction has been approved by shareholders, restricted to a hold period and is expected to close on June 25, 2024.